Protein kinase D1 overexpression potentiates epidermal growth factor signaling pathway in MCF-7 cells

Area of Science:

• Molecular Biology
• Cell Signaling
• Cancer Research

Background:

• Protein kinase D1 (PKD1) is a serine-threonine kinase involved in cell proliferation, migration, invasion, and apoptosis.
• PKD1 activation by growth factors suggests its role in tumorigenesis and tumor progression.
• The precise regulation of intracellular signaling pathways by PKD1 requires further clarification.

Purpose of the Study:

• To investigate the role of Protein kinase D1 (PKD1) expression levels in regulating the epidermal growth factor (EGF) signaling pathway.
• To elucidate how PKD1 influences EGF-induced downstream signaling in human breast cancer cells.

Main Methods:

• Utilized human breast cancer cells (MCF-7) with varying levels of PKD1 expression (overexpressing and control).
• Analyzed EGF-stimulated phosphorylation of key signaling proteins, including Akt and extracellular-regulated kinase (ERK1/2).
• Employed pharmacological inhibition and siRNA-mediated knockdown of PKD1 to assess its functional impact.

Main Results:

• PKD1 expression levels modulated the tumor growth-promoting EGF signaling pathway.
• PKD1 overexpression significantly enhanced EGF-induced phosphorylation of Akt (at T308 and S473) and ERK1/2.
• Pharmacological inhibition or knockdown of PKD1 reduced EGF-stimulated Akt and ERK phosphorylation in PKD1-overexpressing cells.

Conclusions:

• PKD1 expression level is a critical determinant in regulating the EGF signaling pathway.
• These findings underscore the crucial role of PKD1 in tumorigenesis.
• Targeting PKD1 may offer therapeutic strategies for cancers driven by EGF signaling.